The Dilemma of COVID-19, Aging, and Cardiovascular Disease

This Viewpoint discusses whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19).

Read the full article here

Related Articles